nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—CYP3A5—Temsirolimus—kidney cancer	0.0913	0.141	CbGbCtD
Modafinil—CYP3A4—Everolimus—kidney cancer	0.0527	0.0813	CbGbCtD
Modafinil—CYP1A2—Pazopanib—kidney cancer	0.0357	0.055	CbGbCtD
Modafinil—CYP3A4—Temsirolimus—kidney cancer	0.0356	0.0549	CbGbCtD
Modafinil—CYP2B6—Sorafenib—kidney cancer	0.0353	0.0545	CbGbCtD
Modafinil—CYP3A5—Erlotinib—kidney cancer	0.0342	0.0528	CbGbCtD
Modafinil—CYP2C9—Capecitabine—kidney cancer	0.0335	0.0517	CbGbCtD
Modafinil—CYP3A5—Paclitaxel—kidney cancer	0.0313	0.0483	CbGbCtD
Modafinil—CYP3A5—Sorafenib—kidney cancer	0.0278	0.0429	CbGbCtD
Modafinil—CYP3A5—Vincristine—kidney cancer	0.027	0.0417	CbGbCtD
Modafinil—CYP1A2—Erlotinib—kidney cancer	0.0255	0.0393	CbGbCtD
Modafinil—CYP3A5—Sunitinib—kidney cancer	0.0225	0.0348	CbGbCtD
Modafinil—CYP2C19—Sorafenib—kidney cancer	0.0224	0.0346	CbGbCtD
Modafinil—CYP2B6—Doxorubicin—kidney cancer	0.0214	0.033	CbGbCtD
Modafinil—CYP2C9—Paclitaxel—kidney cancer	0.021	0.0324	CbGbCtD
Modafinil—CYP1A2—Sorafenib—kidney cancer	0.0207	0.0319	CbGbCtD
Modafinil—CYP3A4—Pazopanib—kidney cancer	0.0187	0.0288	CbGbCtD
Modafinil—CYP2C9—Sorafenib—kidney cancer	0.0187	0.0288	CbGbCtD
Modafinil—CYP3A4—Erlotinib—kidney cancer	0.0133	0.0206	CbGbCtD
Modafinil—CYP3A4—Paclitaxel—kidney cancer	0.0122	0.0188	CbGbCtD
Modafinil—CYP3A4—Sorafenib—kidney cancer	0.0108	0.0167	CbGbCtD
Modafinil—CYP3A4—Vinblastine—kidney cancer	0.0107	0.0165	CbGbCtD
Modafinil—CYP3A4—Vincristine—kidney cancer	0.0105	0.0162	CbGbCtD
Modafinil—CYP3A4—Sunitinib—kidney cancer	0.00879	0.0136	CbGbCtD
Modafinil—CYP3A4—Doxorubicin—kidney cancer	0.00658	0.0102	CbGbCtD
Modafinil—CYP2C19—urine—kidney cancer	0.00297	0.165	CbGeAlD
Modafinil—CYP1A2—urine—kidney cancer	0.00242	0.135	CbGeAlD
Modafinil—CYP2C9—urine—kidney cancer	0.0023	0.128	CbGeAlD
Modafinil—CYP3A4—urine—kidney cancer	0.00175	0.0978	CbGeAlD
Modafinil—ADRA1B—renal system—kidney cancer	0.00128	0.0712	CbGeAlD
Modafinil—ADRA1B—kidney—kidney cancer	0.00123	0.0688	CbGeAlD
Modafinil—CYP3A5—nephron tubule—kidney cancer	0.000629	0.0351	CbGeAlD
Modafinil—CYP2B6—nephron tubule—kidney cancer	0.000625	0.0349	CbGeAlD
Modafinil—CYP1A2—renal system—kidney cancer	0.000593	0.0331	CbGeAlD
Modafinil—Nepafenac—PTGS1—kidney cancer	0.000581	0.136	CrCbGaD
Modafinil—CYP3A5—renal system—kidney cancer	0.000572	0.0319	CbGeAlD
Modafinil—CYP2B6—renal system—kidney cancer	0.000568	0.0317	CbGeAlD
Modafinil—CYP3A5—kidney—kidney cancer	0.000553	0.0308	CbGeAlD
Modafinil—CYP2B6—kidney—kidney cancer	0.000549	0.0306	CbGeAlD
Modafinil—CYP3A5—cortex of kidney—kidney cancer	0.000538	0.03	CbGeAlD
Modafinil—CYP2B6—gonad—kidney cancer	0.000509	0.0284	CbGeAlD
Modafinil—Oxaprozin—PTGS1—kidney cancer	0.000483	0.113	CrCbGaD
Modafinil—CYP3A4—renal system—kidney cancer	0.000429	0.0239	CbGeAlD
Modafinil—CYP3A4—kidney—kidney cancer	0.000415	0.0231	CbGeAlD
Modafinil—Fenoprofen—PTGS1—kidney cancer	0.000399	0.0936	CrCbGaD
Modafinil—Nepafenac—PTGS2—kidney cancer	0.000332	0.0779	CrCbGaD
Modafinil—Phenylbutazone—PTGS1—kidney cancer	0.000319	0.0749	CrCbGaD
Modafinil—Warfarin—CYP1A1—kidney cancer	0.000279	0.0655	CrCbGaD
Modafinil—Oxaprozin—PTGS2—kidney cancer	0.000276	0.0647	CrCbGaD
Modafinil—Ketoprofen—PTGS1—kidney cancer	0.000235	0.0552	CrCbGaD
Modafinil—Fenoprofen—PTGS2—kidney cancer	0.000228	0.0535	CrCbGaD
Modafinil—Cinnarizine—CYP1A1—kidney cancer	0.000221	0.0519	CrCbGaD
Modafinil—Phenylbutazone—PTGS2—kidney cancer	0.000182	0.0428	CrCbGaD
Modafinil—Diphenhydramine—PTGS1—kidney cancer	0.000174	0.0407	CrCbGaD
Modafinil—Arrhythmia—Capecitabine—kidney cancer	0.000148	0.000521	CcSEcCtD
Modafinil—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000148	0.00052	CcSEcCtD
Modafinil—Discomfort—Paclitaxel—kidney cancer	0.000148	0.00052	CcSEcCtD
Modafinil—Fatigue—Gemcitabine—kidney cancer	0.000148	0.00052	CcSEcCtD
Modafinil—Gastrointestinal pain—Vincristine—kidney cancer	0.000148	0.000519	CcSEcCtD
Modafinil—Cardiac arrest—Doxorubicin—kidney cancer	0.000147	0.000516	CcSEcCtD
Modafinil—Dizziness—Sorafenib—kidney cancer	0.000147	0.000516	CcSEcCtD
Modafinil—Pain—Gemcitabine—kidney cancer	0.000146	0.000515	CcSEcCtD
Modafinil—Constipation—Gemcitabine—kidney cancer	0.000146	0.000515	CcSEcCtD
Modafinil—Nausea—Erlotinib—kidney cancer	0.000146	0.000515	CcSEcCtD
Modafinil—Dry mouth—Paclitaxel—kidney cancer	0.000146	0.000515	CcSEcCtD
Modafinil—Mood swings—Doxorubicin—kidney cancer	0.000146	0.000514	CcSEcCtD
Modafinil—Diarrhoea—Sunitinib—kidney cancer	0.000146	0.000514	CcSEcCtD
Modafinil—Ataxia—Doxorubicin—kidney cancer	0.000145	0.000511	CcSEcCtD
Modafinil—Mental disorder—Capecitabine—kidney cancer	0.000145	0.000511	CcSEcCtD
Modafinil—Asthenia—Dactinomycin—kidney cancer	0.000145	0.00051	CcSEcCtD
Modafinil—Confusional state—Paclitaxel—kidney cancer	0.000145	0.000509	CcSEcCtD
Modafinil—Malnutrition—Capecitabine—kidney cancer	0.000144	0.000507	CcSEcCtD
Modafinil—Anaphylactic shock—Paclitaxel—kidney cancer	0.000143	0.000505	CcSEcCtD
Modafinil—Oedema—Paclitaxel—kidney cancer	0.000143	0.000505	CcSEcCtD
Modafinil—Body temperature increased—Vincristine—kidney cancer	0.000143	0.000502	CcSEcCtD
Modafinil—Abdominal pain—Vincristine—kidney cancer	0.000143	0.000502	CcSEcCtD
Modafinil—Infection—Paclitaxel—kidney cancer	0.000142	0.000501	CcSEcCtD
Modafinil—Flatulence—Capecitabine—kidney cancer	0.000142	0.0005	CcSEcCtD
Modafinil—Dry skin—Doxorubicin—kidney cancer	0.000141	0.000498	CcSEcCtD
Modafinil—Dysgeusia—Capecitabine—kidney cancer	0.000141	0.000497	CcSEcCtD
Modafinil—Dizziness—Sunitinib—kidney cancer	0.000141	0.000497	CcSEcCtD
Modafinil—Feeling abnormal—Gemcitabine—kidney cancer	0.000141	0.000497	CcSEcCtD
Modafinil—Shock—Paclitaxel—kidney cancer	0.000141	0.000496	CcSEcCtD
Modafinil—Vomiting—Sorafenib—kidney cancer	0.000141	0.000496	CcSEcCtD
Modafinil—Abdominal pain upper—Doxorubicin—kidney cancer	0.000141	0.000496	CcSEcCtD
Modafinil—Nervous system disorder—Paclitaxel—kidney cancer	0.000141	0.000495	CcSEcCtD
Modafinil—Tachycardia—Paclitaxel—kidney cancer	0.00014	0.000492	CcSEcCtD
Modafinil—Rash—Sorafenib—kidney cancer	0.00014	0.000492	CcSEcCtD
Modafinil—Dermatitis—Sorafenib—kidney cancer	0.00014	0.000492	CcSEcCtD
Modafinil—Back pain—Capecitabine—kidney cancer	0.000139	0.000491	CcSEcCtD
Modafinil—Skin disorder—Paclitaxel—kidney cancer	0.000139	0.00049	CcSEcCtD
Modafinil—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000139	0.000489	CcSEcCtD
Modafinil—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000139	0.000489	CcSEcCtD
Modafinil—Headache—Sorafenib—kidney cancer	0.000139	0.000489	CcSEcCtD
Modafinil—Muscle spasms—Capecitabine—kidney cancer	0.000139	0.000488	CcSEcCtD
Modafinil—Hyperhidrosis—Paclitaxel—kidney cancer	0.000139	0.000488	CcSEcCtD
Modafinil—Diarrhoea—Dactinomycin—kidney cancer	0.000138	0.000486	CcSEcCtD
Modafinil—Anorexia—Paclitaxel—kidney cancer	0.000137	0.000481	CcSEcCtD
Modafinil—Muscular weakness—Doxorubicin—kidney cancer	0.000136	0.000479	CcSEcCtD
Modafinil—Vomiting—Sunitinib—kidney cancer	0.000136	0.000478	CcSEcCtD
Modafinil—Body temperature increased—Gemcitabine—kidney cancer	0.000135	0.000476	CcSEcCtD
Modafinil—Tremor—Capecitabine—kidney cancer	0.000135	0.000475	CcSEcCtD
Modafinil—Ketoprofen—PTGS2—kidney cancer	0.000135	0.0316	CrCbGaD
Modafinil—Rash—Sunitinib—kidney cancer	0.000135	0.000474	CcSEcCtD
Modafinil—Dermatitis—Sunitinib—kidney cancer	0.000134	0.000473	CcSEcCtD
Modafinil—Hypotension—Paclitaxel—kidney cancer	0.000134	0.000471	CcSEcCtD
Modafinil—Ill-defined disorder—Capecitabine—kidney cancer	0.000134	0.000471	CcSEcCtD
Modafinil—Headache—Sunitinib—kidney cancer	0.000134	0.000471	CcSEcCtD
Modafinil—Influenza—Doxorubicin—kidney cancer	0.000133	0.000469	CcSEcCtD
Modafinil—Asthma—Doxorubicin—kidney cancer	0.000133	0.000469	CcSEcCtD
Modafinil—Anaemia—Capecitabine—kidney cancer	0.000133	0.000469	CcSEcCtD
Modafinil—Hypersensitivity—Vincristine—kidney cancer	0.000133	0.000468	CcSEcCtD
Modafinil—Eosinophilia—Doxorubicin—kidney cancer	0.000132	0.000465	CcSEcCtD
Modafinil—Nausea—Sorafenib—kidney cancer	0.000132	0.000464	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000131	0.00046	CcSEcCtD
Modafinil—Malaise—Capecitabine—kidney cancer	0.00013	0.000458	CcSEcCtD
Modafinil—Insomnia—Paclitaxel—kidney cancer	0.00013	0.000456	CcSEcCtD
Modafinil—Vertigo—Capecitabine—kidney cancer	0.00013	0.000456	CcSEcCtD
Modafinil—Asthenia—Vincristine—kidney cancer	0.00013	0.000456	CcSEcCtD
Modafinil—Syncope—Capecitabine—kidney cancer	0.000129	0.000455	CcSEcCtD
Modafinil—Paraesthesia—Paclitaxel—kidney cancer	0.000129	0.000453	CcSEcCtD
Modafinil—Vomiting—Dactinomycin—kidney cancer	0.000128	0.000452	CcSEcCtD
Modafinil—Bronchitis—Doxorubicin—kidney cancer	0.000128	0.000451	CcSEcCtD
Modafinil—Dyspnoea—Paclitaxel—kidney cancer	0.000128	0.00045	CcSEcCtD
Modafinil—Somnolence—Paclitaxel—kidney cancer	0.000127	0.000449	CcSEcCtD
Modafinil—Palpitations—Capecitabine—kidney cancer	0.000127	0.000448	CcSEcCtD
Modafinil—Rash—Dactinomycin—kidney cancer	0.000127	0.000448	CcSEcCtD
Modafinil—Nausea—Sunitinib—kidney cancer	0.000127	0.000446	CcSEcCtD
Modafinil—Loss of consciousness—Capecitabine—kidney cancer	0.000127	0.000446	CcSEcCtD
Modafinil—Pancytopenia—Doxorubicin—kidney cancer	0.000127	0.000446	CcSEcCtD
Modafinil—Dyspepsia—Paclitaxel—kidney cancer	0.000126	0.000444	CcSEcCtD
Modafinil—Cough—Capecitabine—kidney cancer	0.000126	0.000443	CcSEcCtD
Modafinil—Decreased appetite—Paclitaxel—kidney cancer	0.000125	0.000439	CcSEcCtD
Modafinil—Hypertension—Capecitabine—kidney cancer	0.000124	0.000438	CcSEcCtD
Modafinil—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000124	0.000436	CcSEcCtD
Modafinil—Fatigue—Paclitaxel—kidney cancer	0.000124	0.000435	CcSEcCtD
Modafinil—Diarrhoea—Vincristine—kidney cancer	0.000124	0.000435	CcSEcCtD
Modafinil—Pollakiuria—Doxorubicin—kidney cancer	0.000123	0.000434	CcSEcCtD
Modafinil—Asthenia—Gemcitabine—kidney cancer	0.000123	0.000432	CcSEcCtD
Modafinil—Chest pain—Capecitabine—kidney cancer	0.000123	0.000432	CcSEcCtD
Modafinil—Arthralgia—Capecitabine—kidney cancer	0.000123	0.000432	CcSEcCtD
Modafinil—Myalgia—Capecitabine—kidney cancer	0.000123	0.000432	CcSEcCtD
Modafinil—Pain—Paclitaxel—kidney cancer	0.000123	0.000431	CcSEcCtD
Modafinil—Constipation—Paclitaxel—kidney cancer	0.000123	0.000431	CcSEcCtD
Modafinil—Anxiety—Capecitabine—kidney cancer	0.000122	0.00043	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000122	0.000429	CcSEcCtD
Modafinil—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000122	0.000428	CcSEcCtD
Modafinil—Weight increased—Doxorubicin—kidney cancer	0.000121	0.000427	CcSEcCtD
Modafinil—Discomfort—Capecitabine—kidney cancer	0.000121	0.000427	CcSEcCtD
Modafinil—Pruritus—Gemcitabine—kidney cancer	0.000121	0.000426	CcSEcCtD
Modafinil—Weight decreased—Doxorubicin—kidney cancer	0.000121	0.000425	CcSEcCtD
Modafinil—Hyperglycaemia—Doxorubicin—kidney cancer	0.00012	0.000423	CcSEcCtD
Modafinil—Dry mouth—Capecitabine—kidney cancer	0.00012	0.000422	CcSEcCtD
Modafinil—Nausea—Dactinomycin—kidney cancer	0.00012	0.000422	CcSEcCtD
Modafinil—Pneumonia—Doxorubicin—kidney cancer	0.00012	0.000421	CcSEcCtD
Modafinil—Dizziness—Vincristine—kidney cancer	0.000119	0.00042	CcSEcCtD
Modafinil—Drowsiness—Doxorubicin—kidney cancer	0.000119	0.000418	CcSEcCtD
Modafinil—Fentanyl—ABCB1—kidney cancer	0.000119	0.0279	CrCbGaD
Modafinil—Confusional state—Capecitabine—kidney cancer	0.000119	0.000418	CcSEcCtD
Modafinil—Feeling abnormal—Paclitaxel—kidney cancer	0.000118	0.000416	CcSEcCtD
Modafinil—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000118	0.000415	CcSEcCtD
Modafinil—Oedema—Capecitabine—kidney cancer	0.000118	0.000414	CcSEcCtD
Modafinil—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000117	0.000413	CcSEcCtD
Modafinil—Diarrhoea—Gemcitabine—kidney cancer	0.000117	0.000412	CcSEcCtD
Modafinil—Infection—Capecitabine—kidney cancer	0.000117	0.000411	CcSEcCtD
Modafinil—Stomatitis—Doxorubicin—kidney cancer	0.000116	0.000408	CcSEcCtD
Modafinil—Shock—Capecitabine—kidney cancer	0.000116	0.000407	CcSEcCtD
Modafinil—Urinary tract infection—Doxorubicin—kidney cancer	0.000116	0.000407	CcSEcCtD
Modafinil—Conjunctivitis—Doxorubicin—kidney cancer	0.000116	0.000407	CcSEcCtD
Modafinil—Nervous system disorder—Capecitabine—kidney cancer	0.000115	0.000406	CcSEcCtD
Modafinil—Tachycardia—Capecitabine—kidney cancer	0.000115	0.000404	CcSEcCtD
Modafinil—Vomiting—Vincristine—kidney cancer	0.000115	0.000404	CcSEcCtD
Modafinil—Skin disorder—Capecitabine—kidney cancer	0.000114	0.000402	CcSEcCtD
Modafinil—Sweating—Doxorubicin—kidney cancer	0.000114	0.000401	CcSEcCtD
Modafinil—Urticaria—Paclitaxel—kidney cancer	0.000114	0.000401	CcSEcCtD
Modafinil—Rash—Vincristine—kidney cancer	0.000114	0.000401	CcSEcCtD
Modafinil—Hyperhidrosis—Capecitabine—kidney cancer	0.000114	0.0004	CcSEcCtD
Modafinil—Dermatitis—Vincristine—kidney cancer	0.000114	0.0004	CcSEcCtD
Modafinil—Haematuria—Doxorubicin—kidney cancer	0.000113	0.000399	CcSEcCtD
Modafinil—Body temperature increased—Paclitaxel—kidney cancer	0.000113	0.000399	CcSEcCtD
Modafinil—Abdominal pain—Paclitaxel—kidney cancer	0.000113	0.000399	CcSEcCtD
Modafinil—Headache—Vincristine—kidney cancer	0.000113	0.000398	CcSEcCtD
Modafinil—Epistaxis—Doxorubicin—kidney cancer	0.000112	0.000395	CcSEcCtD
Modafinil—Anorexia—Capecitabine—kidney cancer	0.000112	0.000395	CcSEcCtD
Modafinil—Sinusitis—Doxorubicin—kidney cancer	0.000112	0.000393	CcSEcCtD
Modafinil—Agranulocytosis—Doxorubicin—kidney cancer	0.000111	0.000391	CcSEcCtD
Modafinil—Carbamazepine—ABCB1—kidney cancer	0.000111	0.026	CrCbGaD
Modafinil—Hypotension—Capecitabine—kidney cancer	0.00011	0.000387	CcSEcCtD
Modafinil—Vomiting—Gemcitabine—kidney cancer	0.000109	0.000383	CcSEcCtD
Modafinil—Bradycardia—Doxorubicin—kidney cancer	0.000109	0.000382	CcSEcCtD
Modafinil—Rash—Gemcitabine—kidney cancer	0.000108	0.00038	CcSEcCtD
Modafinil—Dermatitis—Gemcitabine—kidney cancer	0.000108	0.00038	CcSEcCtD
Modafinil—Phenytoin—ABCB1—kidney cancer	0.000108	0.0253	CrCbGaD
Modafinil—Headache—Gemcitabine—kidney cancer	0.000107	0.000378	CcSEcCtD
Modafinil—Nausea—Vincristine—kidney cancer	0.000107	0.000377	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000107	0.000377	CcSEcCtD
Modafinil—Rhinitis—Doxorubicin—kidney cancer	0.000107	0.000377	CcSEcCtD
Modafinil—Insomnia—Capecitabine—kidney cancer	0.000106	0.000375	CcSEcCtD
Modafinil—Pharyngitis—Doxorubicin—kidney cancer	0.000106	0.000373	CcSEcCtD
Modafinil—Paraesthesia—Capecitabine—kidney cancer	0.000106	0.000372	CcSEcCtD
Modafinil—Hypersensitivity—Paclitaxel—kidney cancer	0.000106	0.000372	CcSEcCtD
Modafinil—Urinary tract disorder—Doxorubicin—kidney cancer	0.000105	0.000371	CcSEcCtD
Modafinil—Oedema peripheral—Doxorubicin—kidney cancer	0.000105	0.00037	CcSEcCtD
Modafinil—Connective tissue disorder—Doxorubicin—kidney cancer	0.000105	0.000369	CcSEcCtD
Modafinil—Dyspnoea—Capecitabine—kidney cancer	0.000105	0.000369	CcSEcCtD
Modafinil—Urethral disorder—Doxorubicin—kidney cancer	0.000105	0.000368	CcSEcCtD
Modafinil—Dyspepsia—Capecitabine—kidney cancer	0.000104	0.000364	CcSEcCtD
Modafinil—Visual impairment—Doxorubicin—kidney cancer	0.000103	0.000362	CcSEcCtD
Modafinil—Asthenia—Paclitaxel—kidney cancer	0.000103	0.000362	CcSEcCtD
Modafinil—Decreased appetite—Capecitabine—kidney cancer	0.000102	0.00036	CcSEcCtD
Modafinil—Nausea—Gemcitabine—kidney cancer	0.000102	0.000358	CcSEcCtD
Modafinil—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000102	0.000357	CcSEcCtD
Modafinil—Fatigue—Capecitabine—kidney cancer	0.000101	0.000357	CcSEcCtD
Modafinil—Pruritus—Paclitaxel—kidney cancer	0.000101	0.000357	CcSEcCtD
Modafinil—Erythema multiforme—Doxorubicin—kidney cancer	0.000101	0.000355	CcSEcCtD
Modafinil—Pain—Capecitabine—kidney cancer	0.000101	0.000354	CcSEcCtD
Modafinil—Constipation—Capecitabine—kidney cancer	0.000101	0.000354	CcSEcCtD
Modafinil—Cardiac disorder—Doxorubicin—kidney cancer	9.91e-05	0.000349	CcSEcCtD
Modafinil—Diarrhoea—Paclitaxel—kidney cancer	9.81e-05	0.000345	CcSEcCtD
Modafinil—Feeling abnormal—Capecitabine—kidney cancer	9.7e-05	0.000341	CcSEcCtD
Modafinil—Angiopathy—Doxorubicin—kidney cancer	9.69e-05	0.000341	CcSEcCtD
Modafinil—Immune system disorder—Doxorubicin—kidney cancer	9.64e-05	0.000339	CcSEcCtD
Modafinil—Gastrointestinal pain—Capecitabine—kidney cancer	9.62e-05	0.000339	CcSEcCtD
Modafinil—Mediastinal disorder—Doxorubicin—kidney cancer	9.62e-05	0.000339	CcSEcCtD
Modafinil—Chills—Doxorubicin—kidney cancer	9.58e-05	0.000337	CcSEcCtD
Modafinil—Arrhythmia—Doxorubicin—kidney cancer	9.54e-05	0.000336	CcSEcCtD
Modafinil—Dizziness—Paclitaxel—kidney cancer	9.48e-05	0.000334	CcSEcCtD
Modafinil—Mental disorder—Doxorubicin—kidney cancer	9.35e-05	0.000329	CcSEcCtD
Modafinil—Urticaria—Capecitabine—kidney cancer	9.35e-05	0.000329	CcSEcCtD
Modafinil—Abdominal pain—Capecitabine—kidney cancer	9.3e-05	0.000327	CcSEcCtD
Modafinil—Body temperature increased—Capecitabine—kidney cancer	9.3e-05	0.000327	CcSEcCtD
Modafinil—Malnutrition—Doxorubicin—kidney cancer	9.29e-05	0.000327	CcSEcCtD
Modafinil—Flatulence—Doxorubicin—kidney cancer	9.16e-05	0.000322	CcSEcCtD
Modafinil—Tension—Doxorubicin—kidney cancer	9.12e-05	0.000321	CcSEcCtD
Modafinil—Vomiting—Paclitaxel—kidney cancer	9.12e-05	0.000321	CcSEcCtD
Modafinil—Dysgeusia—Doxorubicin—kidney cancer	9.1e-05	0.00032	CcSEcCtD
Modafinil—Rash—Paclitaxel—kidney cancer	9.04e-05	0.000318	CcSEcCtD
Modafinil—Dermatitis—Paclitaxel—kidney cancer	9.03e-05	0.000318	CcSEcCtD
Modafinil—Nervousness—Doxorubicin—kidney cancer	9.03e-05	0.000318	CcSEcCtD
Modafinil—Back pain—Doxorubicin—kidney cancer	8.99e-05	0.000316	CcSEcCtD
Modafinil—Headache—Paclitaxel—kidney cancer	8.98e-05	0.000316	CcSEcCtD
Modafinil—Muscle spasms—Doxorubicin—kidney cancer	8.94e-05	0.000314	CcSEcCtD
Modafinil—Hypersensitivity—Capecitabine—kidney cancer	8.67e-05	0.000305	CcSEcCtD
Modafinil—Ill-defined disorder—Doxorubicin—kidney cancer	8.62e-05	0.000303	CcSEcCtD
Modafinil—Anaemia—Doxorubicin—kidney cancer	8.59e-05	0.000302	CcSEcCtD
Modafinil—Agitation—Doxorubicin—kidney cancer	8.54e-05	0.000301	CcSEcCtD
Modafinil—Nausea—Paclitaxel—kidney cancer	8.52e-05	0.0003	CcSEcCtD
Modafinil—Asthenia—Capecitabine—kidney cancer	8.44e-05	0.000297	CcSEcCtD
Modafinil—Malaise—Doxorubicin—kidney cancer	8.38e-05	0.000295	CcSEcCtD
Modafinil—Vertigo—Doxorubicin—kidney cancer	8.35e-05	0.000294	CcSEcCtD
Modafinil—Syncope—Doxorubicin—kidney cancer	8.34e-05	0.000293	CcSEcCtD
Modafinil—Pruritus—Capecitabine—kidney cancer	8.33e-05	0.000293	CcSEcCtD
Modafinil—Palpitations—Doxorubicin—kidney cancer	8.21e-05	0.000289	CcSEcCtD
Modafinil—Loss of consciousness—Doxorubicin—kidney cancer	8.17e-05	0.000287	CcSEcCtD
Modafinil—Methadone—ABCB1—kidney cancer	8.15e-05	0.0191	CrCbGaD
Modafinil—Cough—Doxorubicin—kidney cancer	8.11e-05	0.000285	CcSEcCtD
Modafinil—Convulsion—Doxorubicin—kidney cancer	8.05e-05	0.000283	CcSEcCtD
Modafinil—Diarrhoea—Capecitabine—kidney cancer	8.05e-05	0.000283	CcSEcCtD
Modafinil—Hypertension—Doxorubicin—kidney cancer	8.02e-05	0.000282	CcSEcCtD
Modafinil—Myalgia—Doxorubicin—kidney cancer	7.91e-05	0.000278	CcSEcCtD
Modafinil—Arthralgia—Doxorubicin—kidney cancer	7.91e-05	0.000278	CcSEcCtD
Modafinil—Chest pain—Doxorubicin—kidney cancer	7.91e-05	0.000278	CcSEcCtD
Modafinil—Anxiety—Doxorubicin—kidney cancer	7.89e-05	0.000277	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	7.86e-05	0.000277	CcSEcCtD
Modafinil—Discomfort—Doxorubicin—kidney cancer	7.82e-05	0.000275	CcSEcCtD
Modafinil—Dizziness—Capecitabine—kidney cancer	7.78e-05	0.000274	CcSEcCtD
Modafinil—Dry mouth—Doxorubicin—kidney cancer	7.74e-05	0.000272	CcSEcCtD
Modafinil—Confusional state—Doxorubicin—kidney cancer	7.65e-05	0.000269	CcSEcCtD
Modafinil—Oedema—Doxorubicin—kidney cancer	7.59e-05	0.000267	CcSEcCtD
Modafinil—Anaphylactic shock—Doxorubicin—kidney cancer	7.59e-05	0.000267	CcSEcCtD
Modafinil—Infection—Doxorubicin—kidney cancer	7.54e-05	0.000265	CcSEcCtD
Modafinil—Vomiting—Capecitabine—kidney cancer	7.48e-05	0.000263	CcSEcCtD
Modafinil—Shock—Doxorubicin—kidney cancer	7.46e-05	0.000263	CcSEcCtD
Modafinil—Nervous system disorder—Doxorubicin—kidney cancer	7.44e-05	0.000262	CcSEcCtD
Modafinil—Rash—Capecitabine—kidney cancer	7.42e-05	0.000261	CcSEcCtD
Modafinil—Dermatitis—Capecitabine—kidney cancer	7.41e-05	0.000261	CcSEcCtD
Modafinil—Tachycardia—Doxorubicin—kidney cancer	7.4e-05	0.00026	CcSEcCtD
Modafinil—Headache—Capecitabine—kidney cancer	7.37e-05	0.000259	CcSEcCtD
Modafinil—Skin disorder—Doxorubicin—kidney cancer	7.37e-05	0.000259	CcSEcCtD
Modafinil—Hyperhidrosis—Doxorubicin—kidney cancer	7.33e-05	0.000258	CcSEcCtD
Modafinil—Anorexia—Doxorubicin—kidney cancer	7.23e-05	0.000254	CcSEcCtD
Modafinil—Hypotension—Doxorubicin—kidney cancer	7.09e-05	0.000249	CcSEcCtD
Modafinil—Nausea—Capecitabine—kidney cancer	6.99e-05	0.000246	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.91e-05	0.000243	CcSEcCtD
Modafinil—Insomnia—Doxorubicin—kidney cancer	6.86e-05	0.000241	CcSEcCtD
Modafinil—Paraesthesia—Doxorubicin—kidney cancer	6.81e-05	0.00024	CcSEcCtD
Modafinil—Dyspnoea—Doxorubicin—kidney cancer	6.76e-05	0.000238	CcSEcCtD
Modafinil—Somnolence—Doxorubicin—kidney cancer	6.74e-05	0.000237	CcSEcCtD
Modafinil—Dyspepsia—Doxorubicin—kidney cancer	6.68e-05	0.000235	CcSEcCtD
Modafinil—Decreased appetite—Doxorubicin—kidney cancer	6.59e-05	0.000232	CcSEcCtD
Modafinil—Gastrointestinal disorder—Doxorubicin—kidney cancer	6.55e-05	0.00023	CcSEcCtD
Modafinil—Fatigue—Doxorubicin—kidney cancer	6.54e-05	0.00023	CcSEcCtD
Modafinil—Pain—Doxorubicin—kidney cancer	6.49e-05	0.000228	CcSEcCtD
Modafinil—Constipation—Doxorubicin—kidney cancer	6.49e-05	0.000228	CcSEcCtD
Modafinil—Feeling abnormal—Doxorubicin—kidney cancer	6.25e-05	0.00022	CcSEcCtD
Modafinil—Gastrointestinal pain—Doxorubicin—kidney cancer	6.2e-05	0.000218	CcSEcCtD
Modafinil—Urticaria—Doxorubicin—kidney cancer	6.03e-05	0.000212	CcSEcCtD
Modafinil—Abdominal pain—Doxorubicin—kidney cancer	6e-05	0.000211	CcSEcCtD
Modafinil—Body temperature increased—Doxorubicin—kidney cancer	6e-05	0.000211	CcSEcCtD
Modafinil—Hypersensitivity—Doxorubicin—kidney cancer	5.59e-05	0.000197	CcSEcCtD
Modafinil—Asthenia—Doxorubicin—kidney cancer	5.44e-05	0.000192	CcSEcCtD
Modafinil—Pruritus—Doxorubicin—kidney cancer	5.37e-05	0.000189	CcSEcCtD
Modafinil—Diarrhoea—Doxorubicin—kidney cancer	5.19e-05	0.000183	CcSEcCtD
Modafinil—Dizziness—Doxorubicin—kidney cancer	5.02e-05	0.000177	CcSEcCtD
Modafinil—Vomiting—Doxorubicin—kidney cancer	4.82e-05	0.00017	CcSEcCtD
Modafinil—Rash—Doxorubicin—kidney cancer	4.78e-05	0.000168	CcSEcCtD
Modafinil—Dermatitis—Doxorubicin—kidney cancer	4.78e-05	0.000168	CcSEcCtD
Modafinil—Headache—Doxorubicin—kidney cancer	4.75e-05	0.000167	CcSEcCtD
Modafinil—Nausea—Doxorubicin—kidney cancer	4.51e-05	0.000159	CcSEcCtD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.44e-05	0.000539	CbGpPWpGaD
Modafinil—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.43e-05	0.000537	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—LDHB—kidney cancer	2.4e-05	0.00053	CbGpPWpGaD
Modafinil—ADRA1B—G alpha (q) signalling events—PIK3CA—kidney cancer	2.4e-05	0.000529	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.4e-05	0.000529	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PDHB—kidney cancer	2.39e-05	0.000527	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—POMC—kidney cancer	2.38e-05	0.000526	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.38e-05	0.000525	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	2.34e-05	0.000515	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—FH—kidney cancer	2.33e-05	0.000513	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—APRT—kidney cancer	2.33e-05	0.000513	CbGpPWpGaD
Modafinil—SLC6A3—Neuronal System—MAPK1—kidney cancer	2.31e-05	0.000509	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PPAT—kidney cancer	2.28e-05	0.000503	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GLIPR1—kidney cancer	2.28e-05	0.000503	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.27e-05	0.000501	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.25e-05	0.000497	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CCBL1—kidney cancer	2.25e-05	0.000496	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.23e-05	0.000492	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GPC3—kidney cancer	2.19e-05	0.000482	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ACY1—kidney cancer	2.17e-05	0.000479	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	2.15e-05	0.000474	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AKAP13—kidney cancer	2.14e-05	0.000473	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CASP2—kidney cancer	2.14e-05	0.000473	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CA9—kidney cancer	2.13e-05	0.00047	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CA2—kidney cancer	2.13e-05	0.000469	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—FH—kidney cancer	2.12e-05	0.000468	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—APRT—kidney cancer	2.12e-05	0.000468	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CA9—kidney cancer	2.08e-05	0.00046	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ALAD—kidney cancer	2.07e-05	0.000457	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.07e-05	0.000457	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.03e-05	0.000448	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ST3GAL2—kidney cancer	2.02e-05	0.000446	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GPC3—kidney cancer	1.99e-05	0.00044	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ALDH1A1—kidney cancer	1.98e-05	0.000436	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—GRB7—kidney cancer	1.96e-05	0.000432	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.95e-05	0.00043	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PPAT—kidney cancer	1.95e-05	0.00043	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CA2—kidney cancer	1.94e-05	0.000428	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.92e-05	0.000424	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.9e-05	0.00042	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PGK1—kidney cancer	1.9e-05	0.000418	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.9e-05	0.000418	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ALAD—kidney cancer	1.89e-05	0.000417	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—LDHB—kidney cancer	1.86e-05	0.00041	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PDHB—kidney cancer	1.85e-05	0.000407	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.84e-05	0.000407	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—POMC—kidney cancer	1.84e-05	0.000406	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ITPR2—kidney cancer	1.82e-05	0.000402	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CRABP1—kidney cancer	1.81e-05	0.0004	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—APRT—kidney cancer	1.81e-05	0.0004	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—FH—kidney cancer	1.81e-05	0.0004	CbGpPWpGaD
Modafinil—SLC6A3—Transmembrane transport of small molecules—RAF1—kidney cancer	1.81e-05	0.000399	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.8e-05	0.000398	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CRABP1—kidney cancer	1.77e-05	0.000391	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.77e-05	0.000391	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CCBL1—kidney cancer	1.73e-05	0.000383	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PGK1—kidney cancer	1.73e-05	0.000381	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.73e-05	0.000381	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GPC3—kidney cancer	1.7e-05	0.000376	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—LDHB—kidney cancer	1.69e-05	0.000374	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ITPR2—kidney cancer	1.69e-05	0.000372	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CA2—kidney cancer	1.66e-05	0.000365	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CTNNA1—kidney cancer	1.65e-05	0.000364	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ITPR2—kidney cancer	1.65e-05	0.000363	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HSPB1—kidney cancer	1.64e-05	0.000362	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EIF4EBP1—kidney cancer	1.64e-05	0.000362	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALAD—kidney cancer	1.61e-05	0.000356	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CA9—kidney cancer	1.61e-05	0.000355	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.58e-05	0.000348	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.58e-05	0.000347	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.54e-05	0.00034	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GSTT1—kidney cancer	1.54e-05	0.000339	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ACHE—kidney cancer	1.54e-05	0.000339	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ANXA1—kidney cancer	1.53e-05	0.000337	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TSC1—kidney cancer	1.53e-05	0.000337	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PSMD7—kidney cancer	1.53e-05	0.000337	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.5e-05	0.000332	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PPAT—kidney cancer	1.5e-05	0.000332	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GSTT1—kidney cancer	1.5e-05	0.000331	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ACHE—kidney cancer	1.5e-05	0.000331	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FLT1—kidney cancer	1.48e-05	0.000326	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.48e-05	0.000326	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PGK1—kidney cancer	1.48e-05	0.000326	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CA9—kidney cancer	1.47e-05	0.000324	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—SCARB1—kidney cancer	1.46e-05	0.000321	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—LDHB—kidney cancer	1.45e-05	0.000319	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTGS1—kidney cancer	1.44e-05	0.000318	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.44e-05	0.000317	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—SCARB1—kidney cancer	1.42e-05	0.000314	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PSMD7—kidney cancer	1.41e-05	0.000312	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTGS1—kidney cancer	1.41e-05	0.000311	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—FH—kidney cancer	1.4e-05	0.000308	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—APRT—kidney cancer	1.4e-05	0.000308	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—POMC—kidney cancer	1.39e-05	0.000308	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PSMD7—kidney cancer	1.38e-05	0.000305	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PAK1—kidney cancer	1.37e-05	0.000302	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—JUNB—kidney cancer	1.37e-05	0.000302	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CRABP1—kidney cancer	1.37e-05	0.000302	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—BCHE—kidney cancer	1.34e-05	0.000295	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—SLC5A5—kidney cancer	1.32e-05	0.000292	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GPC3—kidney cancer	1.31e-05	0.00029	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—BCHE—kidney cancer	1.31e-05	0.000289	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—SLC5A5—kidney cancer	1.29e-05	0.000285	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CA2—kidney cancer	1.28e-05	0.000282	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—SLC2A1—kidney cancer	1.28e-05	0.000282	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ITPR2—kidney cancer	1.27e-05	0.000281	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—POMC—kidney cancer	1.27e-05	0.000279	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CA9—kidney cancer	1.26e-05	0.000277	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CRABP1—kidney cancer	1.25e-05	0.000276	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—SLC2A1—kidney cancer	1.25e-05	0.000275	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALAD—kidney cancer	1.25e-05	0.000275	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.23e-05	0.000271	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.22e-05	0.000268	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.19e-05	0.000262	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.17e-05	0.000259	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTT1—kidney cancer	1.16e-05	0.000256	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ACHE—kidney cancer	1.16e-05	0.000256	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ITPR2—kidney cancer	1.16e-05	0.000256	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PGK1—kidney cancer	1.14e-05	0.000251	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.14e-05	0.000251	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IGF2—kidney cancer	1.12e-05	0.000247	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—LDHB—kidney cancer	1.12e-05	0.000247	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CDKN2B—kidney cancer	1.12e-05	0.000246	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—SCARB1—kidney cancer	1.1e-05	0.000243	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTGS1—kidney cancer	1.09e-05	0.00024	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IGF1R—kidney cancer	1.08e-05	0.000239	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.07e-05	0.000236	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CRABP1—kidney cancer	1.07e-05	0.000235	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PSMD7—kidney cancer	1.07e-05	0.000235	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GSTP1—kidney cancer	1.07e-05	0.000235	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTT1—kidney cancer	1.06e-05	0.000234	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ACHE—kidney cancer	1.06e-05	0.000234	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—RAF1—kidney cancer	1.04e-05	0.00023	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GSTP1—kidney cancer	1.04e-05	0.00023	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—IL2—kidney cancer	1.03e-05	0.000227	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—BCHE—kidney cancer	1.01e-05	0.000223	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ABCB1—kidney cancer	1.01e-05	0.000222	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SCARB1—kidney cancer	1e-05	0.000221	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—SLC5A5—kidney cancer	1e-05	0.00022	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ITPR2—kidney cancer	9.93e-06	0.000219	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTGS1—kidney cancer	9.93e-06	0.000219	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ABCB1—kidney cancer	9.86e-06	0.000217	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GSTM1—kidney cancer	9.79e-06	0.000216	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PSMD7—kidney cancer	9.74e-06	0.000215	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CA9—kidney cancer	9.69e-06	0.000214	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—SLC2A1—kidney cancer	9.66e-06	0.000213	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GSTM1—kidney cancer	9.57e-06	0.000211	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.37e-06	0.000207	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL2—kidney cancer	9.36e-06	0.000206	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP1A1—kidney cancer	9.28e-06	0.000205	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—BCHE—kidney cancer	9.23e-06	0.000204	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.15e-06	0.000202	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SLC5A5—kidney cancer	9.12e-06	0.000201	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP1A1—kidney cancer	9.07e-06	0.0002	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTT1—kidney cancer	9.05e-06	0.0002	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ACHE—kidney cancer	9.05e-06	0.0002	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HIF1A—kidney cancer	8.92e-06	0.000197	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TSC2—kidney cancer	8.9e-06	0.000196	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SLC2A1—kidney cancer	8.8e-06	0.000194	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SCARB1—kidney cancer	8.57e-06	0.000189	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.54e-06	0.000188	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KDR—kidney cancer	8.53e-06	0.000188	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTGS1—kidney cancer	8.48e-06	0.000187	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PSMD7—kidney cancer	8.32e-06	0.000183	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CRABP1—kidney cancer	8.24e-06	0.000182	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.17e-06	0.00018	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTP1—kidney cancer	8.05e-06	0.000178	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—BCHE—kidney cancer	7.89e-06	0.000174	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—APC—kidney cancer	7.86e-06	0.000173	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KIT—kidney cancer	7.86e-06	0.000173	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SLC5A5—kidney cancer	7.79e-06	0.000172	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ITPR2—kidney cancer	7.66e-06	0.000169	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ABCB1—kidney cancer	7.62e-06	0.000168	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—MAPK3—kidney cancer	7.53e-06	0.000166	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SLC2A1—kidney cancer	7.52e-06	0.000166	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—POMC—kidney cancer	7.48e-06	0.000165	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.45e-06	0.000164	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTM1—kidney cancer	7.4e-06	0.000163	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—BRAF—kidney cancer	7.39e-06	0.000163	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTP1—kidney cancer	7.34e-06	0.000162	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.3e-06	0.000161	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—MAPK1—kidney cancer	7.16e-06	0.000158	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP1A1—kidney cancer	7.02e-06	0.000155	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ACHE—kidney cancer	6.99e-06	0.000154	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTT1—kidney cancer	6.99e-06	0.000154	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ABCB1—kidney cancer	6.95e-06	0.000153	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—POMC—kidney cancer	6.92e-06	0.000153	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CA—kidney cancer	6.84e-06	0.000151	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—POMC—kidney cancer	6.77e-06	0.000149	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—KRAS—kidney cancer	6.76e-06	0.000149	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTM1—kidney cancer	6.75e-06	0.000149	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SCARB1—kidney cancer	6.61e-06	0.000146	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTGS1—kidney cancer	6.55e-06	0.000144	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PSMD7—kidney cancer	6.42e-06	0.000142	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP1A1—kidney cancer	6.4e-06	0.000141	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.37e-06	0.00014	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTP1—kidney cancer	6.27e-06	0.000138	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CA—kidney cancer	6.21e-06	0.000137	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—RAF1—kidney cancer	6.17e-06	0.000136	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—RELA—kidney cancer	6.14e-06	0.000135	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ERBB2—kidney cancer	6.1e-06	0.000135	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—BCHE—kidney cancer	6.09e-06	0.000134	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MTOR—kidney cancer	6.02e-06	0.000133	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC5A5—kidney cancer	6.01e-06	0.000133	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ABCB1—kidney cancer	5.94e-06	0.000131	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC2A1—kidney cancer	5.81e-06	0.000128	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTM1—kidney cancer	5.77e-06	0.000127	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.76e-06	0.000127	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CDKN1B—kidney cancer	5.65e-06	0.000125	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL2—kidney cancer	5.53e-06	0.000122	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTGS2—kidney cancer	5.52e-06	0.000122	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP1A1—kidney cancer	5.47e-06	0.000121	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTGS2—kidney cancer	5.4e-06	0.000119	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCND1—kidney cancer	5.39e-06	0.000119	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—JUN—kidney cancer	5.38e-06	0.000119	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CTNNB1—kidney cancer	5.34e-06	0.000118	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.26e-06	0.000116	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—POMC—kidney cancer	5.23e-06	0.000115	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PTEN—kidney cancer	5.2e-06	0.000115	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTP1—kidney cancer	4.84e-06	0.000107	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTEN—kidney cancer	4.81e-06	0.000106	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—POMC—kidney cancer	4.77e-06	0.000105	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTEN—kidney cancer	4.71e-06	0.000104	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—VEGFA—kidney cancer	4.7e-06	0.000104	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ABCB1—kidney cancer	4.58e-06	0.000101	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.49e-06	9.9e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTM1—kidney cancer	4.45e-06	9.81e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MAPK3—kidney cancer	4.45e-06	9.8e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MYC—kidney cancer	4.32e-06	9.54e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MAPK1—kidney cancer	4.23e-06	9.33e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP1A1—kidney cancer	4.22e-06	9.3e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTGS2—kidney cancer	4.17e-06	9.2e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—POMC—kidney cancer	4.08e-06	8.99e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KRAS—kidney cancer	4e-06	8.81e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTGS2—kidney cancer	3.8e-06	8.39e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CA—kidney cancer	3.67e-06	8.1e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTEN—kidney cancer	3.64e-06	8.02e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TP53—kidney cancer	3.55e-06	7.83e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CA—kidney cancer	3.4e-06	7.49e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CA—kidney cancer	3.32e-06	7.32e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTEN—kidney cancer	3.32e-06	7.32e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTGS2—kidney cancer	3.25e-06	7.17e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—POMC—kidney cancer	3.15e-06	6.94e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTEN—kidney cancer	2.84e-06	6.25e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CA—kidney cancer	2.57e-06	5.66e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTGS2—kidney cancer	2.51e-06	5.53e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CA—kidney cancer	2.34e-06	5.16e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTEN—kidney cancer	2.19e-06	4.83e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CA—kidney cancer	2e-06	4.41e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.54e-06	3.4e-05	CbGpPWpGaD
